HU Jie, WEI Xue-wu. Something Varies Due To Different Conditions: EGFR Mutant Clonal Architecture Affects The Efficacy of EGFR Tyrosine Kinase Inhibitor[J]. Journal of Evidence-Based Medicine, 2021, 21(1): 14-17. DOI: 10.12019/j.issn.1671-5144.2021.01.004
Citation:
|
HU Jie, WEI Xue-wu. Something Varies Due To Different Conditions: EGFR Mutant Clonal Architecture Affects The Efficacy of EGFR Tyrosine Kinase Inhibitor[J]. Journal of Evidence-Based Medicine, 2021, 21(1): 14-17. DOI: 10.12019/j.issn.1671-5144.2021.01.004
|
HU Jie, WEI Xue-wu. Something Varies Due To Different Conditions: EGFR Mutant Clonal Architecture Affects The Efficacy of EGFR Tyrosine Kinase Inhibitor[J]. Journal of Evidence-Based Medicine, 2021, 21(1): 14-17. DOI: 10.12019/j.issn.1671-5144.2021.01.004
Citation:
|
HU Jie, WEI Xue-wu. Something Varies Due To Different Conditions: EGFR Mutant Clonal Architecture Affects The Efficacy of EGFR Tyrosine Kinase Inhibitor[J]. Journal of Evidence-Based Medicine, 2021, 21(1): 14-17. DOI: 10.12019/j.issn.1671-5144.2021.01.004
|